Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia

Zhi, Feng; Cao, Xiangshan; Xie, Xiaobao; Wang, Biao; Dong, Weimin; Gu, Weiying; Ling, Yun; Wang, Rong; Yang, Yilin; Liu, Yan
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The disease is characterized by various cytogenetic and molecular abnormalities with distinct prognoses and gene expression profiles. Emerging evidence has suggested that circulating microRNAs (miRNAs) could serve as noninvasive biomarkers for cancer detection; however, little is known about circulating miRNA profiles in AML patients. In this study, a genome-wide serum miRNA expression analysis was performed using Solexa sequencing for initial screen, followed by validation with real-time PCR assays. The analysis was conducted on training and verification sets of serum samples from 140 newly diagnosed AML patients and 135 normal adult donors. After a two-phase selection and validation process, 6 miRNAs, miR-10a-5p, miR-93-5p, miR-129-5p, miR-155-5p, miR-181b-5p and miR-320d, were found to have significantly different expression levels in AML compared with control serum samples. Furthermore, unsupervised clustering analysis revealed the remarkable ability of the 6-miRNA profile to differentiate between AML patients and normal controls. The areas under the ROC curve for the selected miRNAs ranged from 0.8129 to 0.9531. More importantly, miR-181b-5p levels in serum were significantly associated with overall survival. These data demonstrated that the expression patterns of circulating miRNAs were systematically altered in AML and miR-181b-5p may serve as a predictor for overall survival in AML patients.


Related Articles

  • MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia. Díaz-Beyá, M; Brunet, S; Nomdedéu, J; Tejero, R; Díaz, T; Pratcorona, M; Tormo, M; Ribera, J M; Escoda, L; Duarte, R; Gallardo, D; Heras, I; Queipo de Llano, M P; Bargay, J; Monzo, M; Sierra, J; Navarro, A; Esteve, J // Leukemia (08876924);Apr2014, Vol. 28 Issue 4, p804 

    Acute myeloid leukemia (AML) is a heterogeneous disease, and optimal treatment varies according to cytogenetic risk factors and molecular markers. Several studies have demonstrated the prognostic importance of microRNAs (miRNAs) in AML. Here we report a potential association between miRNA...

  • Identification of let-7a-2-3p or/and miR-188-5p as Prognostic Biomarkers in Cytogenetically Normal Acute Myeloid Leukemia. Jinlong, Shi; Lin, Fu; Yonghui, Li; Li, Yu; Weidong, Wang // PLoS ONE;Feb2015, Vol. 10 Issue 2, p1 

    Cytogenetically normal acute myeloid leukemia (CN-AML) is the largest and most heterogeneous AML subgroup. It lacks sensitive and specific biomarkers. Emerging evidences have suggested that microRNAs are involved in the pathogenesis of various leukemias. This paper evaluated the association...

  • Gene expression profiling in MDS and AML: potential and future avenues. Theilgaard-Mönch, K.; Boultwood, J.; Ferrari, S.; Giannopoulos, K.; Hernandez-Rivas, J. M.; Kohlmann, A.; Morgan, M.; Porse, B.; Tagliafico, E.; Zwaan, C. M.; Wainscoat, J.; Van den Heuvel-Eibrink, M. M.; Mills, K.; Bullinger, L. // Leukemia (08876924);Jun2011, Vol. 25 Issue 6, p909 

    Today, the classification systems for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) already incorporate cytogenetic and molecular genetic aberrations in an attempt to better reflect disease biology. However, in many MDS/AML patients no genetic aberrations have been identified...

  • Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia. Li Liu; Ren'an Chen; Yangping Zhang; Wen Fan; Fang Xiao; Xueqian Yan // Diagnostic Pathology;Jul2015, Vol. 10 Issue 1, p1 

    Background: Dysregulation of circulating miR-328 has been identified in several tumors and is associated with prognosis of patients. However, the expression pattern of miR-328 and the impact on prognosis has not yet been studied in acute myeloid leukemia (AML). The purpose of this study is to...

  • RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML. Lichtenegger, Felix; Kondla, Isabell; Krempasky, Michael; Weber, Anna; Herold, Tobias; Krupka, Christina; Spiekermann, Karsten; Schneider, Stephanie; Büchner, Thomas; Berdel, Wolfgang; Wörmann, Bernhard; Hiddemann, Wolfgang; Subklewe, Marion // Cancer Immunology, Immunotherapy;Dec2015, Vol. 64 Issue 12, p1505 

    Immune checkpoint molecules are highly relevant as potential prognostic markers and therapeutic targets in malignant diseases. HVEM belongs to the TNF receptor family and provides stimulatory as well as inhibitory signals depending on the ligand. Abnormal HVEM expression has been described in...

  • Identification of miRNAs Expression Profile in Gastric Cancer Using Self-Organizing Maps (SOM). Gomes, Larissa Luz; Moreira, Fabiano Cordeiro; Hamoy, Igor Guerreiro; Santos, Sidney; Assumpção, Paulo; Santana, Ádamo L.; Ribeiro-dos-Santos, Ândrea // Bioinformation;2014, Vol. 10 Issue 5, p246 

    In this paper, an unsupervised artificial neural network was implemented to identify the patters of specific signatures. The network was based on the differential expression of miRNAs (under or over expression) found in healthy or cancerous gastric tissues. Among the tissues analyzes, the neural...

  • Circulating MicroRNAs: Molecular Microsensors in Gastrointestinal Cancer. Blanco-Calvo, Moisés; Calvo, Lourdes; Figueroa, Angélica; Haz-Conde, Mar; Antón-Aparicio, Luis; Valladares-Ayerbes, Manuel // Sensors (14248220);2012, Vol. 12 Issue 7, p9349 

    MicroRNAs (miRNAs) are small molecules of single strand non-coding RNAs,which are able to regulate gene expression. miRNAs have been involved in multiple cellular processes, such as proliferation, apoptosis and differentiation, thus alterations in miRNA expression have been shown to be directly...

  • MicroRNAs in an Oral Cancer Context – from Basic Biology to Clinical Utility. Gorenchtein, M.; Poh, C.F.; Saini, R.; Garnis, C. // Journal of Dental Research;May2012, Vol. 91 Issue 5, p440 

    Oral cancer is one of the most commonly diagnosed malignancies worldwide. Its dismal five-year survival rate of ~50% has barely changed for decades. A better understanding of the molecular basis of tumorigenesis – with particular emphasis on disease initiation and progression – is...

  • High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia. Song, J H; Kweon, S H; Kim, H-J; Lee, T-H; Min, W-S; Kim, Y-K; Hwang, S Y; Kim, T S // British Journal of Cancer;6/26/2012, Vol. 107 Issue 1, p108 

    Background:Cytosine arabinoside-based chemotherapy coupled with anthracycline is currently the first-line treatment for acute myeloid leukaemia (AML), but diverse responses to the regimen constitute obstacles to successful treatment. Therefore, outcome prediction to chemotherapy at diagnosis is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics